NVS
Novartis AG
97.72
USD
This page is just a preview of the data found in TrendSpider’s full version
Novartis AG stock is up 4.22% since 30 days ago. The next earnings date is Jan 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 62.5% of the previous 23 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 8 PUTs, 2 CALLs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 17 Nov 18:55 | 19 Apr, 2024 | 90.00 | 473 | ||
| 20 Nov 15:12 | 19 Apr, 2024 | 92.50 | 155 | ||
| 21 Nov 18:25 | 17 Jan, 2025 | 95.00 | 25 | ||
| 22 Nov 14:35 | 19 Jan, 2024 | 97.50 | 261 | ||
| 22 Nov 14:37 | 19 Apr, 2024 | 105.00 | 74 | ||
| 22 Nov 15:29 | 17 Jan, 2025 | 97.50 | 0 | ||
| 22 Nov 17:55 | 19 Apr, 2024 | 105.00 | 74 | ||
| 27 Nov 14:37 | 19 Apr, 2024 | 105.00 | 253 | ||
| 27 Nov 14:57 | 19 Apr, 2024 | 100.00 | 217 | ||
| 27 Nov 17:41 | 19 Jan, 2024 | 105.00 | 156 |
Novartis AG researches, develops, manufactures, and markets healthcare products. The company operates through two segments, Innovative Medicines and Sandoz. Sandoz provides finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals.
